Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Hormone Therapy in Locally Advanced Prostate Cancer
NCT04220398Unknown
- Sponsor
- Renji Hospital
- Start
- Jan 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of docetaxel in prostate cancer (PCa), sponsored by Renji Hospital. Status: unknown.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04220398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04220398.